Literature DB >> 26632604

Procoagulant and fibrinolytic activity after polytrauma in rat.

Xiaowu Wu1, Daniel N Darlington2, Andrew P Cap2.   

Abstract

The purpose of this study was to determine whether trauma-induced coagulopathy is due to changes in 1) thrombin activity, 2) plasmin activity, and/or 3) factors that stimulate or inhibit thrombin or plasmin. Sprague-Dawley rats were anesthetized with 1-2% isoflurane/100% oxygen, and their left femoral artery and vein were cannulated. Polytrauma included right femur fracture, and damage to the small intestines, the left and medial liver lobes, and right leg skeletal muscle. Rats were then bled 40% of blood volume. Plasma samples were taken before trauma, and at 30, 60, 120, and 240 min. Polytrauma and hemorrhage led to a significant fall in prothrombin levels. However, circulating thrombin activity did not change significantly over time. Antithrombin III and α2 macroglobulin fell significantly by 2 h, then rose by 4 h. Soluble thrombomodulin was significantly elevated over the 4 h. Circulating plasmin activity, plasminogen, and D-dimers were elevated for the entire 4 h. Tissue plasminogen activator (tPA) was elevated at 30 min, then decreased below baseline levels after 1 h. Plasminogen activator inhibitor-1 was significantly elevated at 2-4 h. Neither tissue factor pathway inhibitor nor thrombin activatable fibrinolysis inhibitor changed significantly over time. The levels of prothrombin and plasminogen were 30-100 times higher than their respective active enzymes. Polytrauma and hemorrhage in rats lead to a fibrinolytic coagulopathy, as demonstrated by an elevation in plasmin activity, D-dimers, and tPA. These results are consistent with the observed clinical benefit of tranexamic acid in trauma patients.

Entities:  

Keywords:  coagulation; fibrinolysis; hemorrhage; plasmin; thrombin

Mesh:

Substances:

Year:  2015        PMID: 26632604      PMCID: PMC4796743          DOI: 10.1152/ajpregu.00401.2015

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  38 in total

1.  Increasing trauma deaths in the United States.

Authors:  Peter Rhee; Bellal Joseph; Viraj Pandit; Hassan Aziz; Gary Vercruysse; Narong Kulvatunyou; Randall S Friese
Journal:  Ann Surg       Date:  2014-07       Impact factor: 12.969

2.  Proteolytic processing of human coagulation factor IX by plasmin.

Authors:  J A Samis; G D Ramsey; J B Walker; M E Nesheim; A R Giles
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

3.  Platelets modulate the proteolysis of factor VIII:C protein by plasmin.

Authors:  M E Rick; D M Krizek
Journal:  Blood       Date:  1986-06       Impact factor: 22.113

4.  Mechanistic determinates of the acute coagulopathy of trauma (ACoT) in patients requiring emergency surgery.

Authors:  Sherry L Sixta; Quinton M Hatch; Nena Matijevic; Charles E Wade; John B Holcomb; Bryan A Cotton
Journal:  Int J Burns Trauma       Date:  2012-12-05

5.  Hyperfibrinolysis elicited via thromboelastography predicts mortality in trauma.

Authors:  Crystal Ives; Kenji Inaba; Bernardino C Branco; Obi Okoye; Herbert Schochl; Peep Talving; Lydia Lam; Ira Shulman; Janice Nelson; Demetrios Demetriades
Journal:  J Am Coll Surg       Date:  2012-07-04       Impact factor: 6.113

6.  Acute coagulopathy of trauma in the rat.

Authors:  Daniel N Darlington; Teresa Craig; Mary D Gonzales; Martin G Schwacha; Andrew P Cap; Michael A Dubick
Journal:  Shock       Date:  2013-05       Impact factor: 3.454

Review 7.  α-2-Macroglobulin: a physiological guardian.

Authors:  Ahmed A Rehman; Haseeb Ahsan; Fahim H Khan
Journal:  J Cell Physiol       Date:  2013-08       Impact factor: 6.384

Review 8.  Ten-year analysis of transfusion in Operation Iraqi Freedom and Operation Enduring Freedom: increased plasma and platelet use correlates with improved survival.

Authors:  Heather F Pidcoke; James K Aden; Alejandra G Mora; Matthew A Borgman; Philip C Spinella; Michael A Dubick; Lorne H Blackbourne; Andrew P Cap
Journal:  J Trauma Acute Care Surg       Date:  2012-12       Impact factor: 3.313

9.  Thrombelastography and biomarker profiles in acute coagulopathy of trauma: a prospective study.

Authors:  Sisse R Ostrowski; Anne Marie Sørensen; Claus F Larsen; Pär I Johansson
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2011-10-26       Impact factor: 2.953

10.  The incidence and magnitude of fibrinolytic activation in trauma patients.

Authors:  I Raza; R Davenport; C Rourke; S Platton; J Manson; C Spoors; S Khan; H D De'Ath; S Allard; D P Hart; K J Pasi; B J Hunt; S Stanworth; P K MacCallum; K Brohi
Journal:  J Thromb Haemost       Date:  2013-02       Impact factor: 5.824

View more
  16 in total

1.  Platelet dysfunction during trauma involves diverse signaling pathways and an inhibitory activity in patient-derived plasma.

Authors:  Christopher C Verni; Antonio Davila; Steve Balian; Carrie A Sims; Scott L Diamond
Journal:  J Trauma Acute Care Surg       Date:  2019-02       Impact factor: 3.313

2.  Onset of Coagulation Function Recovery Is Delayed in Severely Injured Trauma Patients with Venous Thromboembolism.

Authors:  Belinda H McCully; Christopher R Connelly; Kelly A Fair; John B Holcomb; Erin E Fox; Charles E Wade; Eileen M Bulger; Martin A Schreiber
Journal:  J Am Coll Surg       Date:  2017-03-16       Impact factor: 6.113

3.  A Retrospective Study of Transfusion Requirements in Trauma Patients Receiving Tranexamic Acid.

Authors:  Brian Cornelius; Kelsey Moody; Katelyn Hopper; Phillip Kilgore; Urska Cvek; Marjan Trutschl; Angela P Cornelius
Journal:  J Trauma Nurs       Date:  2019 May/Jun       Impact factor: 1.010

Review 4.  Coagulopathy induced by traumatic brain injury: systemic manifestation of a localized injury.

Authors:  Jianning Zhang; Fangyi Zhang; Jing-Fei Dong
Journal:  Blood       Date:  2018-03-05       Impact factor: 22.113

5.  Platelet-mimicking procoagulant nanoparticles augment hemostasis in animal models of bleeding.

Authors:  Ujjal Didar Singh Sekhon; Kelsey Swingle; Aditya Girish; Norman Luc; Maria de la Fuente; Jurgis Alvikas; Shannon Haldeman; Adnan Hassoune; Kaisal Shah; Youjoung Kim; Steven Eppell; Jeffrey Capadona; Andrew Shoffstall; Matthew D Neal; Wei Li; Marvin Nieman; Anirban Sen Gupta
Journal:  Sci Transl Med       Date:  2022-01-26       Impact factor: 19.319

6.  Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT.

Authors:  Ian Roberts; Haleema Shakur-Still; Amy Aeron-Thomas; Danielle Beaumont; Antonio Belli; Amy Brenner; Madeleine Cargill; Rizwana Chaudhri; Nicolas Douglas; Lauren Frimley; Catherine Gilliam; Amber Geer; Zahra Jamal; Rashid Jooma; Raoul Mansukhani; Alec Miners; Jason Pott; Danielle Prowse; Temitayo Shokunbi; Jack Williams
Journal:  Health Technol Assess       Date:  2021-04       Impact factor: 4.014

7.  Tranexamic acid in bleeding trauma patients: an exploration of benefits and harms.

Authors:  Ian Roberts; Phil Edwards; David Prieto; Miland Joshi; Abda Mahmood; Katharine Ker; Haleema Shakur
Journal:  Trials       Date:  2017-01-31       Impact factor: 2.279

8.  Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2017-04-26       Impact factor: 79.321

9.  Can tranexamic acid reduce the blood transfusion rate in patients undergoing percutaneous nephrolithotomy? A systematic review and meta-analysis.

Authors:  Zhenghao Wang; Xiao He; Yunjin Bai; Jia Wang
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

10.  A clinically relevant and bias-controlled murine model to study acute traumatic coagulopathy.

Authors:  C Gangloff; O Grimault; M Theron; K Pichavant; H Galinat; F Mingant; Y Ozier
Journal:  Sci Rep       Date:  2018-04-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.